Parkside Financial Bank & Trust’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
CP
Parkside Financial Bank & Trust's AGL Position: Q3 2025 in Review
Parkside Financial Bank & Trust sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 12 shares — an estimated $667 sold.
Parkside Financial Bank & Trust first reported a position in AGL in Q4 2021 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.
- Parkside Financial Bank & Trust reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 12 Agilon Health shares in Q3 2025, an estimated $667.
- Parkside Financial Bank & Trust first reported a position in Agilon Health in Q4 2021 and held it in 9 quarters.
- Parkside Financial Bank & Trust's Agilon Health position peaked at $6K in Q4 2021.
- 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.
Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.